A Phase I intermittent dose-escalation trial of ZD1839 (IressaTM) in Japanese patients with solid malignant tumors
- 1 September 2000
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 29 (1) , 71
- https://doi.org/10.1016/s0169-5002(00)80229-9
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: